Brief: Matinas Biopharma Reports Qtrly Loss Per Share $0.03

Matinas BioPharma Holdings

10/05/2023 22:15

May 10 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES A BUSINESS UPDATE
    * MATINAS BIOPHARMA HOLDINGS INC - QTRLY LOSS PER SHARE
$0.03
    * MATINAS BIOPHARMA HOLDINGS - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF MARCH 31, 2023 WERE $24.9 MILLION
    * MATINAS BIOPHARMA HOLDINGS - BELIEVES ITS CASH POSITION IS
SUFFICIENT TO FUND PLANNED OPERATIONS INTO THE SECOND HALF OF
2024

Source text for Eikon:  ID:nGNX43PhWP 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))